The relationship between blood concentration of methadone and its metabolite (EDDP) and clinical signs in methadone-intoxicated people by Ahmadian Ranjbar, Hajar
 Iﺧﻼﺻﻪ ﻓﺎرﺳﻲ                                                                                                     
  
  داﻧﺸﮕﺎه ﻋﻠﻮم ﭘﺰﺷﻜﻲ و ﺧﺪﻣﺎت ﺑﻬﺪاﺷﺘﻲ درﻣﺎﻧﻲ ﻛﺮﻣﺎن
  داﻧﺸﻜﺪه داروﺳﺎزي و ﻋﻠﻮم داروﻳﻲ
 
  
  ﭘﺎﻳﺎن ﻧﺎﻣﻪ دﻛﺘﺮاي ﻋﻤﻮﻣﻲ داروﺳﺎزي
 
 
  ﻋﻨﻮان:
( ﺑﺎ ﻋﻼﺋﻢ PDDEآن) ﺖﻴﻣﺘﺎدون و ﻣﺘﺎﺑﻮﻟ ﻲﻏﻠﻈﺖ ﺧﻮﻧ ﻦﻴارﺗﺒﺎط ﺑ ﻲﺑﺮرﺳ
  در اﻓﺮاد ﻣﺴﻤﻮم ﺷﺪه ﺑﺎ ﻣﺘﺎدون ﻲﻨﻴﺑﺎﻟ
  
  ﺗﻮﺳﻂ:
  ﻫﺎﺟﺮ اﺣﻤﺪﻳﺎن رﻧﺠﺒﺮ
  
  :اﺳﺎﺗﻴﺪ راﻫﻨﻤﺎ
  دﻛﺘﺮ ﻋﻠﻲ ﻣﺎﻧﺪﮔﺎري
  دﻛﺘﺮ ﻣﺼﻄﻔﻲ ﭘﻮرﻧﺎﻣﺪاري
  دﻛﺘﺮ زﻫﺮه ﻋﻘﺎﺑﻴﺎن
  
  
 3901 ﺷﻤﺎره ﭘﺎﻳﺎن ﻧﺎﻣﻪ:            8931 ﺗﺎﺑﺴﺘﺎن
                                                                                                     ﻲﺳرﺎﻓ ﻪﺻﻼﺧII 
 
Kerman Univerrsity of medical sciences 
Faculty of Pharmacy 
 
Pharm. D Thesis 
 
Title 
The relationship between blood concentration of methadone and its 
metabolite (EDDP) and clinical signs in methadone-intoxicated people 
 
 
By: 
Hajar Ahmadian Rangbar 
 
 
Supervisors: 
Dr. Ali Mandegari 
Dr. Mostafa Pournamdari 
Dr.Zohreh Oghabian 
 
 
 
 
Thesis No:1093              Summer1398 
ﺧﻼﺻﻪ ﻓﺎرﺳﻲ                    
 III
  ﺧﻼﺻﻪ ﻓﺎرﺳﻲ
ﺑﺮاي درﻣﺎن دارو  ﻳﻦﻣﻬﻤﺘﺮﺑﻌﻨﻮان  ﺻﻨﺎﻋﻲ اﺳﺖ ﻛﻪﻋﻀﻮي از دﺳﺘﻪ داروﻫﺎي ﻣﺨﺪر  ﻣﺘﺎدون: ﻣﻘﺪﻣﻪ
ﺟﻤﻌﻴﺖ ﻣﺼﺮف ﺑﺎ ﺗﻮﺟﻪ ﺑﻪ اﻓﺰاﻳﺶ . رودﺑﻜﺎر ﻣﻲﻃﺒﻴﻌﻲ  ﻫﺎي ﻃﺒﻴﻌﻲ و ﻧﻴﻤﻪ اﻓﻴﻮناﻋﺘﻴﺎد ﺑﻪ دﻳﮕﺮ ﺷﺒﻪ 
 ﺑﺪﻧﺒﺎل .درﺣﺎل ﮔﺴﺘﺮش اﺳﺖ ﻬﺎﻣﺴﻤﻮﻣﻴﺖ ﻫﺎي ﺣﺎﺻﻞ از آﻧدر ﺣﺎل ﺣﺎﺿﺮ  ،ﻛﻨﻨﺪﮔﺎن ﻣﻮاد ﻣﺨﺪر
 ﺑﺎﻻ رﻓﺘﻪآﻣﺎر ﻣﺴﻤﻮﻣﻴﺖ ﺑﺎ آن ﻫﺎي ﺗﺮك ﻣﻮاد ﻣﺨﺪر در ﺳﺎﻟﻬﺎي اﺧﻴﺮ اﻓﺰاﻳﺶ ﺗﺠﻮﻳﺰ ﻣﺘﺎدون در ﺑﺮﻧﺎﻣﻪ
اﻳﻨﻜﻪ ﺷﻮاﻫﺪ زﻳﺎدي در ﺳﻄﺢ ﺟﻬﺎﻧﻲ در ﻣﺴﻤﻮﻣﻴﺖ ﺑﺎ ﻣﺘﺎدون ﮔﺰارش ﻧﺸﺪه اﻣﺎ در ﺗﻮﺟﻪ ﺑﻪ ﺑﺎ  اﺳﺖ.
م ﻧﻴﺎز ﺑﻪ اﻧﺠﺎﻣﺒﻨﻲ ﺑﺮ ﻣﺴﻤﻮﻣﻴﺖ ﻋﻤﺪي و ﻏﻴﺮ ﻋﻤﺪي ﺑﺎ ﻣﺘﺎدون وﺟﻮد دارد  ﻗﺎﺑﻞ ﺗﻮﺟﻬﻲ ﺷﻮاﻫﺪاﻳﺮان 
و  ﻣﺘﺎدونﻏﻠﻈﺖ اﻳﻦ ﻣﻄﺎﻟﻌﻪ ﺑﺮرﺳﻲ ارﺗﺒﺎط ﺑﻴﻦ  ﻫﺪف .ﻃﻠﺒﺪرا ﻣﻲ زﻣﻴﻨﻪ اﻳﻦ ﻣﻄﺎﻟﻌﺎت ﺑﻴﺸﺘﺮ در
  .ﺑﺎﺷﺪﻣﻲ ﻋﻼﺋﻢ ﺑﺎﻟﻴﻨﻲو  ﻣﺴﻤﻮﻣﻴﺖو ﺷﺪت  در ﭘﻼﺳﻤﺎ PDDE ﻣﺘﺎﺑﻮﻟﻴﺖ آن
ﺑﻴﻤﺎر ﻣﺴﻤﻮم ﺷﺪه ﺑﺎ ﻣﺘﺎدون ﻛﻪ ﺑﻪ ﺑﻴﻤﺎرﺳﺘﺎن اﻓﻀﻠﻲ ﭘﻮر ﺷﻬﺮ  15در اﻳﻦ ﻣﻄﺎﻟﻌﻪ ﺗﻌﺪاد  :روش ﻛﺎر
ﻧﺎﻣﻪ ﭘﺮﺳﺶ ﻳﻚ ﺑﻴﻤﺎران ﻃﻲ ﻫﺎي ﺑﺎﻟﻴﻨﻲﻳﺎﻓﺘﻪاﻃﻼﻋﺎت و  .داده ﺷﺪﻧﺪﻛﺮﻣﺎن ﻣﺮاﺟﻌﻪ ﻛﺮده ﺑﻮدﻧﺪ ﺷﺮﻛﺖ 
 ﺳﺎﻋﺖ ﺑﻌﺪ از ﺷﺮوع درﻣﺎن 42ﺑﺴﺘﺮي و  روز اولدر  ﺧﻮنﻧﻤﻮﻧﻪ ﻫﺎي و از ﻫﺮ ﺑﻴﻤﺎر ﺟﻤﻊ آوري 
ﻳﻚ روش اﺳﺘﺨﺮاج ﺑﻬﻴﻨﻪ  ﭘﻼﺳﻤﺎدر  PDDEﺟﻬﺖ ﺗﻌﻴﻴﻦ ﻣﻘﺪار ﻣﺘﺎدون و ﻣﺘﺎﺑﻮﻟﻴﺖ آن  ﮔﺮﻓﺘﻪ ﺷﺪ.
 ﻓﺎز ﻣﻌﻜﻮس ﺟﻔﺖ ﻳﻮﻧﻲ CLPHﻫﺎ ﻳﻚ روش ﺟﻬﺖ آﻧﺎﻟﻴﺰ اﺳﺘﺎﻧﺪاردﻫﺎ و ﻧﻤﻮﻧﻪﻫﻤﭽﻨﻴﻦ  .ﺳﺎزي ﮔﺮدﻳﺪ
   .ﻫﺎ آﻧﺎﻟﻴﺰ ﺷﺪﻧﺪو ﻧﻤﻮﻧﻪ ﺷﺪ ﮔﺬاريﺗﻮﺳﻌﻪ و ﺻﺤﻪ VUﺑﺎ دﺗﻜﺘﻮر 
دﭘﺮﺳﻴﻮن ﺑﻴﺸﺘﺮﻳﻦ ﻋﻼﺋﻢ ﺑﺎﻟﻴﻨﻲ ﻣﺸﺎﻫﺪه ﺷﺪه در ﮔﺮوه ﻣﻮرد ﻣﻄﺎﻟﻌﻪ ﺷﺎﻣﻞ ﺗﻨﮓ ﺷﺪن ﻣﺮدﻣﻚ،  :ﻳﺎﻓﺘﻪ ﻫﺎ
اﺳﺘﻔﺮاغ و ﺗﺸﻨﺞ ﺑﻮد. ﺑﻴﺸﺘﺮﻳﻦ  ،ﺎب ﻣﺮﻛﺰي، ﻳﺒﻮﺳﺖ، ﮔﻴﺠﻲ، ﺣﺎﻟﺖ ﺗﻬﻮعﺗﻨﻔﺴﻲ، دﭘﺮﺳﻴﻮن ﺳﻴﺴﺘﻢ اﻋﺼ
ﺗﻌﺪاد % ﻣﻮارد ﮔﺰارش ﺷﺪ. 34/8ﻣﺎده ﻣﻮرد ﻣﺼﺮف در اﻓﺮاد ﻣﺴﻤﻮم ﺑﻪ ﻣﺘﺎدون ﺗﺮﻛﻴﺐ آﻣﻔﺘﺎﻣﻴﻦ ﺑﺎ 
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 ﻦﻴ، آﻟﻜﺎﻟﻨﻮﺗﺮاﻧﺴﻔﺮازﻴآﻣ ﻦﻴآﻻﻧ ﻨﻮﺗﺮاﻧﺴﻔﺮاز،ﻴآﺳﭙﺎرﺗﺎت آﻣ ﻦ،ﻴﻨﻴاوره، ﻛﺮاﺗﻣﻘﺎدﻳﺮ ﺧﻮن،  ﺪﻴﺳﻔﮔﻠﺒﻮﻟﻬﺎي 
ﺳﺎﻳﺮ  ؛ وداري داﺷﺖاﻓﺰاﻳﺶ ﻣﻌﻨﻲ لﮔﺮوه ﻛﻨﺘﺮﻧﺴﺒﺖ ﺑﻪ  ﻤﺎرﻴدر ﮔﺮوه ﺑ ﻦﻴروﺑﻲﻠﻴﻓﺴﻔﺎﺗﺎز و ﺑ
ﺗﻮﺳﻌﻪ داده  CLPHروش داري ﻛﻤﺘﺮ ﺑﻮد. ﺑﻪ ﻃﻮر ﻣﻌﻨﻲﺑﺮرﺳﻲ ﺷﺪه ﻓﺎﻛﺘﻮرﻫﺎي ﺧﻮﻧﻲ و ﺑﻴﻮﺷﻴﻤﻴﺎﻳﻲ 
ﺑﺎ ﺿﺮﻳﺐ  PDDEﺑﺮاي  2-04 Lm/gµو ﺑﺮاي ﻣﺘﺎدون  1-04 Lm/gµﻣﺤﺪوده ﻏﻠﻈﺘﻲ  ﺷﺪه در
و  yad-retniدر دو ﺳﻄﺢ  ﻲﻣﻨﺎﺳﺒﻣﺘﺪ دﻗﺖ  ( ﺧﻄﻲ ﺑﻮد.9999.0=2R) ﺧﻴﻠﻲ ﺧﻮبرﮔﺮﺳﻴﻮن 
و  DOLﻣﻘﺎدﻳﺮ  ﺑﻮد.ﺑﺮاي ﻫﺮ دو آﻧﺎﻟﻴﺖ ﺻﺤﺖ ﻗﺎﺑﻞ ﻗﺒﻮل داراي ﻫﻤﭽﻨﻴﻦ و ﻧﺸﺎن داد   etaidemretni
 ﺑﺮاي 0/8  Lm/gµو  0/3  Lm/gµ و ﺑﺮاي ﻣﺘﺎدون  0/5 Lm/gµو  0/1  Lm/gµﺑﻪ ﺗﺮﺗﻴﺐ  QOL
ﺗﻌﻴﻴﻦ ﺷﺪه ﺑﺮاي ﻣﺘﺎدون و   DOLو  QOLﻫﺎ ﻣﻘﺎدﻳﺮي ﻛﻤﺘﺮ از ﺗﻌﻴﻴﻦ ﺷﺪ. ﺗﻤﺎﻣﻲ ﻧﻤﻮﻧﻪ PDDE
در ﻧﻤﻮﻧﻪ  PDDEﻣﺘﺎدون و دﻟﻴﻞ ﻛﻢ ﺑﻮدن ﻏﻠﻈﺖ  ﺑﻪﺗﻮاﻧﺪ ﻣﻲداﺷﺘﻨﺪ ﻛﻪ ﺑﺮ ﺧﻼف اﻧﺘﻈﺎر ﻣﺘﺎﺑﻮﻟﻴﺘﺶ 
   ﺎﺷﺪ.ي ﺧﻮن ﺑﻫﺎ
ﺑﺎ   VUﻓﺎز ﻣﻌﻜﻮس ﺟﻔﺖ ﻳﻮﻧﻲ ﺑﺎ دﺗﻜﺘﻮر  CLPHﻳﻚ روش اﺳﺘﺨﺮاج و آﻧﺎﻟﻴﺰ :ﺑﺤﺚ و ﻧﺘﻴﺠﻪ ﮔﻴﺮي
ﺑﺎ ﮔﺬاري ﺷﺪ. ﻫﺎي ﺑﻴﻮﻟﻮژﻳﻚ ﺗﻮﺳﻌﻪ و ﺻﺤﻪدر ﻧﻤﻮﻧﻪ  PDDEﺑﺮاي ﺗﻌﻴﻴﻦ ﻣﻘﺪار ﻣﺘﺎدون وﻣﻮﻓﻘﻴﺖ 
و ﻧﻴﺎز ﺑﻪ  ﺑﻮدهروش  QOLﻛﻤﺘﺮ از  دو آﻧﺎﻟﻴﺖ ﺳﻄﻮح ﺧﻮﻧﻲ ﺣﺎﺻﻞ از اﻳﻦ ﻣﻄﺎﻟﻌﻪﺗﻮﺟﻪ ﺑﻪ ﻧﺘﺎﻳﺞ 
 SM-CGو  SM-CLاز ﻗﺒﻴﻞ  ﺗﺮ آﻧﺎﻟﻴﺰﻫﺎي ﺣﺴﺎسﻫﺎي ﭘﻴﺸﺮﻓﺘﻪ ﺗﺮ اﺳﺘﺨﺮاج و ﻫﻤﭽﻨﻴﻦ ﺗﻜﻨﻴﻚروش
 ﺑﺎﺷﺪ.ﻣﻲ دارﻧﺪﻗﻮﻳﺘﺮي ﺑﻪ ﻣﺮاﺗﺐ ﻛﻪ دﺗﻜﺘﻮر 
 ، ﺟﻔﺖ ﻳﻮﻧﻲCLPH، ﻣﺴﻤﻮﻣﻴﺖ، ﻋﻼﺋﻢ ﺑﺎﻟﻴﻨﻲ، PDDE، ﻣﺘﺎدون :ﻴﺪيواژﮔﺎن ﻛﻠ
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Abstract 
Introduction: Methadone is a member of the industrial narcotic drugs which is used as the most 
important remedy for the treatment of addiction with other natural and synthetic opioids. 
Considering an increase in drug addicts’ population, intoxication with these materials is raised 
currently. Following an increase in administration of methadone in drug-addiction treatment 
protocols, intoxication with this compound has statistically had a dramatic growth in recent 
years. Despite the fact that there is not much evidence on methadone poisoning worldwide, there 
are many indications of intentional and unintentional poisoning with methadone in Iran which 
suggests further studies in this regard. The aim of this study is to determine the relationship 
between methadone and its metabolite concentration in plasma and severity of poisoning and 
clinical symptoms. 
Methods: Totally, 51 methadone-intoxicated patients admitted in Afzalipour Hospital in Kerman 
were participated in this study. Patients’ information and clinical syptums were collected via a 
questionnaire and blood samples were collected form each patient at the first day and the day of 
hospital leave. In order to determine methadone and its metabolite EDDP concentration in 
plasma, an extraction method was optimized. In addition, an ion-pairing reversed-phase HPLC 
method with UV detection was developed and validated for analysis of standards and samples. 
Results: The most observed clinical syptums in studied group were miosis, respiratory 
depression, CNS depression, constipation, drowsiness, nausea, vomiting and seizure. 
Amphetamine was the most common compound used by methadone-intoxicated patients with a 
relative frequency of 43.8%. The number of white globules, the amounts of urea, creatinine, 
spartate aminotransferase, alanine aminotransferase, alkaline phosphatase and billirobine were 
significantly increased in intoxicated group in comparsion with those of control group; other 
determined hematology and biochemistry factors were significantly lower. The developed HPLC 
method was linear in the concentration range of 1-40 μg/mL for methadone and 2-40 μg/mL for 
EDDP with very good regression coefficient (R2 = 0.9999). The method showed a suitable 
precsion at two inter-day and intermediate levels and also had acceptable accuracy for both 
analytes. The LOD and LOQ values were respectively determined at 0.1 μg/mL and 0.5 μg/mL 
for methadone and at 0.3 μg/mL and 0.8 μg/mL for EDDP. All blood samples had lower amount 
of methadone and its metab However, due to the low concentration of olites than determined 
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LOQ and LOD which could be unexpectedly due to low concentration of methadone and EDDP 
in blood samples. 
Discussion and Conclusion: An extraction procedure and an ion-pairing reversed-phase HPLC 
method were successfully developed and validated for determination of methadone and EDDP in 
biological samples. According to the results of this study, the blood levels of two analytes were 
lower than the LOQ of the mthode and it is necessary to have more advanced extraction methods 
and also more sensitive analysis techniques such as LC-MS and GC-MS which have stronger 
detectors.  
Key words: Methadone, EDDP, Poisoning, Clinical Symptoms, HPLC, Ion-Pairing 
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